Relates to the sale, manufacture, and distribution of vapor products; requires distributors and manufacturers of vapor products to obtain permits; prohibits the sale of illicit vapor products; creates a vapor product directory.
S00902 would significantly expand New York’s regulation of vapor products and nicotine-related e-cigarette supply chains. It amends the Public Health Law to tighten age-verification rules for sales of tobacco products, liquid nicotine, shisha, electronic cigarettes, and vapor products, including making transaction scans mandatory for covered sales and strengthening rules for vending machines that dispense these products. The bill also creates new permit systems for vapor product distributors and manufacturers, with application requirements, background checks, fees, permit terms, and public posting of permit holders by the Department of Health.
The bill further creates a statewide vapor product directory administered by the Attorney General. Beginning in 2026, manufacturers would have to submit attestations showing that their products either were on the U.S. market by August 8, 2018 and had a timely FDA premarket application, or have received FDA marketing authorization. Products not listed in the directory would be deemed unlawful to manufacture, distribute, sell, barter, or furnish in New York. The bill also defines “illicit vapor product” and separately prohibits the sale of such products, with criminal penalties for violations.
In addition to the new directory and permit framework, the bill updates existing shipment and transport prohibitions to cover vapor products more explicitly and increases penalties for violations, including class A misdemeanor treatment for first offenses and class E felony treatment for repeat offenses in certain cases. It also restricts vapor products dealers from purchasing only from permitted distributors or manufacturers, creating a more controlled and traceable market for nicotine vapor products.
The general sentiment reflected in the bill text is regulatory and enforcement-oriented rather than permissive, with a clear public-health focus on youth access, product legitimacy, and compliance with federal FDA requirements. Because there are no committee transcripts or recorded votes provided, there is no direct evidence of support or opposition from legislators in the available materials. The structure of the bill suggests its proponents are likely concerned with curbing illegal vape sales and improving oversight, while likely points of contention would include the compliance burden on manufacturers and distributors, the scope of criminal penalties, and whether the directory/permit system could limit market access for smaller businesses.
The bill would amend multiple sections of the Public Health Law to impose new licensing, verification, and product-listing requirements on the vapor product industry. It would create new state permits for vapor product distributors and manufacturers, require public lists of permit holders, prohibit dealers from buying from unpermitted sources, and establish a state vapor product directory tied to FDA authorization and premarket application status. It also expands unlawful shipment and transport provisions and adds a new offense for selling illicit vapor products, with misdemeanor and felony penalties and civil fines for violations.
The bill’s tone is strongly restrictive and enforcement-focused, indicating a pro-regulation, public-health-oriented approach aimed at reducing youth access and removing unapproved vapor products from the market. No committee discussion or vote history is available, so there is no recorded legislative debate to gauge bipartisan support or opposition. Based on the text alone, the bill appears designed to appeal to lawmakers concerned about vaping enforcement and illicit product sales, while likely drawing resistance from industry stakeholders affected by the new permit and directory requirements.
The most likely points of contention are the new compliance obligations for manufacturers, distributors, and dealers, including permit applications, background checks, fees, and ongoing attestations to the Attorney General. Another likely issue is the bill’s reliance on FDA premarket application and marketing-order status, which could be viewed as creating a narrow pathway for products to remain on the market. The criminal penalties for illicit vapor products and the broad prohibition on products not listed in the directory may also be controversial among retailers and manufacturers, especially smaller or out-of-state businesses that could face added administrative and legal risk.